obesity drug news today glp-1 october 2025 weight loss drugs, such as Ozempic, have helped numerous people drop pounds, but according to a new study, these drugs aren't only good for weight loss. The study found that heart Rhode Island considers ending Medicaid

doi: 10.1210/clinem/dgaf336 19

For example, in terms of weight reduction, considering that tirzepatide has shown a high level of weight loss in several studies, we look forward to a comparative clinical study of tirzepatide versus semaglutide for the treatment of obesity, providing a better option for patients than semaglutide, which is already approved for the chronic management of obesity

In addition, a greater effect of tirzepatide on dose-dependent body weight reduction versus semaglutide was observed (least-squares mean estimated treatment difference of -1.9 kg, -3.6 kg, and -5.5 kg for the three doses

The possible mechanisms are as follows

& Bacon, B

A randomized controlled trial found that GLP-1 mimics, such as exenatide and liraglutide, had a significant weight loss effect on obese/overweight patients without diabetes (171)